Spondylitis Association of America
    Search Our Site:       

















Position Statement from SAA's Medical and Scientific Advisory Board on the COX-2 Inhibitors

11/23/2004

Vioxx belongs to a class of drugs known as the COXIBS. Other examples include Celebrex, Arcoxia, and Bextra. Until more information becomes available, all COXIBs should be regarded as having the potential to increase the risk of adverse cardiovascular events. Patients with past and/or current heart disease, and those at serious risk of heart disease (e.g. diabetics), should check with their physician before continuing to take any of these medications.


STAY INFORMED!

Stay up-to-date on all the latest news and information regarding AS and related diseases with our news magazine, Spondylitis Plus. Your subscription comes free with SAA membership, so click here to join today!

© 2009 Spondylitis Association of America, All Rights Reserved